MedTrace Logo

Evaluation of the CochSyn Device in Clinical Practice

NCT07091071 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2026-02-10

No results posted yet for this study

Summary

This study investigates a new type of auditory evoked brain potentials for the quantification and classification of peripheral hearing damage (The CochSyn Test). The study will investigate the characteristics of this new auditory evoked potential marker in a cohort of people with and without self-reported hearing difficulties and test a new type of hardware that was developed to conduct the test (the CochSyn Device) in clinical practice.

Conditions

  • Hearing Loss, Sensorineural
  • Cochlear Hearing Loss
  • Cochlear Synaptopathy
  • DFNA9

Interventions

DEVICE

CochSyn device

The CochSyn device is intended for use in the evaluation of hearing-related disorders in adults using auditory evoked potentials. The CochSyn device records and analyses biopotential waveforms that can be used for hearing screening and diagnostic applications.

Sponsors & Collaborators

  • University Ghent

    lead OTHER

Principal Investigators

  • Sarah Verhulst, Prof. · University Ghent

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
77 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-29
Primary Completion
2026-01-22
Completion
2026-01-22

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07091071 on ClinicalTrials.gov